Nature of the Business - Additional Information (Details) $ / shares in Units, $ in Thousands				1 Months Ended		3 Months Ended	9 Months Ended
	Feb. 24, 2021 USD ($) shares	Feb. 17, 2021 $ / shares shares	Feb. 05, 2021	Aug. 31, 2022 USD ($)	Mar. 31, 2022 USD ($) shares	Mar. 31, 2021 USD ($) shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) shares	Jun. 30, 2022 shares	Dec. 31, 2021 $ / shares shares	Jun. 30, 2021 shares	Dec. 31, 2020 shares
Nature Of Business Disclosure [Line Items]
Common stock par value | $ / shares							$ 0.001			$ 0.001
Issuance of common stock upon closing of IPO						$ 124,779
Aggregate proceeds from initial public offering	$ 125,000
Proceeds from issuance of common stock								$ 128,240
Cash, cash equivalents and available-for-sale securities							$ 111,900
Initial Public Offering
Nature Of Business Disclosure [Line Items]
Number of shares issued and sold | shares		7,062,000
Stock issued, price per share | $ / shares		$ 18.00
Underwriters
Nature Of Business Disclosure [Line Items]
Number of shares issued and sold | shares	600,000
At-the-Market | Maximum
Nature Of Business Disclosure [Line Items]
Issuance of common stock upon closing of IPO				$ 50,000
Common Stock
Nature Of Business Disclosure [Line Items]
Reverse stock-split, description							On February 5, 2021, the Company’s board of directors approved a 1-for-5.3 reverse stock split of the Company’s common stock.
Reverse stock-split ratio			0.1886
Number of shares issued and sold | shares						7,662,000
Shares outstanding | shares					24,956,556	24,859,038	24,962,875	24,899,200	24,959,848	24,951,983	24,868,817	521,052
Issuance of common stock upon closing of IPO						$ 7
Common Stock | Maximum
Nature Of Business Disclosure [Line Items]
Issuance of common stock upon closing of IPO					$ 200,000
Common Stock | At-the-Market
Nature Of Business Disclosure [Line Items]
Shares outstanding | shares							0
Percentage of compensation on gross proceeds common stock sold							3.00%